Yale study: Many opioid prescriptions allowed without restrictions - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
October 9, 2017 Newswires
Share
Share
Post
Email

Yale study: Many opioid prescriptions allowed without restrictions

New Haven Register (CT)

Oct. 09--NEW HAVEN -- While insurance plans have increased restrictions on the prescribing of opioids, the highly addictive drugs are still easily obtainable without limits such as requiring prior authorization, according to a Yale University study.

The researchers compared formularies for Medicare plans from 2006, 2011 and 2015 and found that two-thirds of these drugs were subject to restrictions. One-third, however, did not have such limits.

"I think we all know that we're in a national opioid crisis right now and we need to know what may be contributing and we need to have all possible strategies at our disposal to help curb this crisis," said Dr. Sanket Dhruva, a cardiologist at the Yale School of Medicine and member of the research team, on Monday.

The study was published Monday in the Annals of Internal Medicine.

The researchers compared Medicare Advantage and Part D formularies for 2006, 2011 and 2015 because Medicare is often a standard other insurers use for their formularies. "Essentially, formularies determine the availability of these medications," Dhruva said. If a drug is not on the formulary, the patient and doctor must go through an appeals process.

"If the drugs are available, the insurance companies can use one of three strategies," he said. They may require prior authorization from the insurance company before the prescription will be approved. They can implement so-called step therapy, in which "a patient must try drug X before he can receive drug Y," Dhruva said. Or they can limit the quantity of drugs that may be dispensed at one time.

Connecticut passed a law in 2016 limiting most opioid prescriptions to seven days, with some exceptions.

The Centers for Disease Control and Prevention issued guidelines in 2016 for opioid prescriptions, but the Yale researchers found that these were not always followed. "Still, a large number of opioids don't have restrictions imposed on them," Dhruva said. "We want to make sure that opioids are going to patients that are going to benefit and are not going out in high doses."

Comparing formularies from 2006 with 2015, "It's an improvement, but I still think we have a ways to go," he said.

The CDC guidelines use a measure called morphine milligram equivalents to compare different opioid medications and call for a limit of 90 per day on that scale.

"They say nothing more than 90 and what we found was, even if there was a quantity limit, 31 percent of the time a patient could receive more than 90 morphine milligram equivalents per day," and 33 percent of the time there were no restrictions placed on the drugs, Dhruva said.

"I think that insurance plans ... should use these tools that are at their disposal to bring their formularies more in line with the CDC's recommendations and we believe this would likely lead to safer opioid prescribing," Dhruva said.

"I think there's an important opportunity here and we hope that the formularies can be part of the solution to addressing this crisis."

More than 900 people died in Connecticut in 2016 of drug overdoses, according to the state's chief medical examiner's office.

Dr. Dan Knecht, head of clinical strategy and policy for Aetna Inc., said the company has instituted restrictions on all opioid prescriptions. As of Jan. 1, "For an initial prescription written, there will be a seven-day limit," he said.

"A research study showed that after a patient receives a prescription of more than seven days of opioids, the likelihood of abuse doubles," he said.

He said the insurer sent letters to the top 1 percent of opioid prescribers warning them that they are "outliers." "We do intervene on these physicians who are excessive prescribers," he said.

Knecht also said Aetna encourages other medications for pain-relief, such as Tylenol and ibuprofen before opioids are prescribed. The company also covers treatments such as physical and occupational therapy, acupuncture and chiropractic, "which are proven treatment modalities that do manage pain," he said.

"Our formulary has safety guardrails to keep our members safe," Knecht said. "But there is a therapeutic relationship between the patient and the physician that we also respect."

According to the CDC, opioid prescriptions peaked in 2010 and declined through 2015, but the dosages increased dramatically. Patients were prescribed an average 180 morphine milligram equivalents per day in 1999 and 640 in 2015.

It is important to prevent patients from becoming addicted to opioids, because many users then move on to illegal street drugs such as heroin or fentanyl. "Once you start, it just opens up the door," Dhruva said. "Of course, [in] the vast majority it doesn't, but we've got young people dying, we've got people addicted. We've got a real problem on our hands."

Contact Ed Stannard at [email protected] or 203-680-9382.

___

(c)2017 the New Haven Register (New Haven, Conn.)

Visit the New Haven Register (New Haven, Conn.) at www.nhregister.com

Distributed by Tribune Content Agency, LLC.

Older

Insurer AIG Predicts $3 billion in Losses From Catastrophes

Newer

Storm saturation: Backlogs grow as $5.3B OKed in Irma claims, aid

Advisor News

  • IRI pitches retirement agenda to Jeffries as democrats shape affordability platform
  • Help child-free clients plan for their later years
  • When new investment trends emerge, Gen Z is most likely generation to be first in
  • Could ‘plain English’ become an advisor’s secret weapon?
  • IRI urges Senate action on 403(b) parity legislation
More Advisor News

Annuity News

  • Guidance, bulletin or reg? NAIC debates form of annuity illustration update
  • Nationwide adds mutual fund-linked strategy to New Heights Select FIA
  • NUNN INTRODUCES BILL TO CUT RED TAPE, GIVE IOWANS CLEARER INSURANCE INFORMATION
  • NAIC working group pressed to accelerate annuity illustration overhaul
  • State Auditor James Brown Kicks Off Life Insurance Awareness Month With Policy Locator Tool
More Annuity News

Health/Employee Benefits News

  • WA approves double-digit rate hike for individual health insurance plans
  • N.C. Insurance Dept.: Mecklenburg County Woman Charged With Medical Insurance Fraud
  • Why life insurance riders aren’t solving the LTC crisis
  • ATTORNEY GENERAL BONTA CONTINUES FIGHT TO PROTECT AFFORDABLE CARE ACT COVERAGE
  • DOULAS ARE JUMPING THROUGH "A LOT OF HOOPS" TO SERVE MEDICAID CLIENTS
Sponsor
More Health/Employee Benefits News

Life Insurance News

  • Capgemini: Life insurers under pressure: 42% of consumers are confused and unconvinced by policies
  • TDCI Reminds Consumers to Focus on the Future During Life Insurance Awareness Month
  • Best’s Market Segment Report: AM Best Maintains Stable Outlook on Malaysia’s Non-Life Insurance Segment
  • Agam Capital Advises JAB Insurance on Completing the Acquisition and Successful Rehabilitation of Columbian Financial Group
  • Former Lawrence County deputy indicted in alleged life insurance fraud scheme
Sponsor
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • Classic Car Insurer OpenRoad Insurance Expands to 40 U.S. States in Two Years
  • How Aspire General Turned an Early Technology Bet Into Claims Automation at Scale with Kyber
  • Adjusto launches AI-Native contents claims services powered by its technology platform
  • URL Insurance Group Celebrates 40 Years of Service, Growth, and Industry Leadership
  • MassMutual Ascend Surpasses $2 Billion in Lifetime Advisory Annuity Sales, Reflecting Continued Momentum in RIA Channel
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.